Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04434196
Brief Title: A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

First Submitted : June 1, 2020
First Submitted that Met QC Criteria : June 12, 2020
First Posted : June 16, 2020

Last Update Submitted that Met QC Criteria : January 15, 2021
Last Update Posted : January 20, 2021